Infant bleeding cases nearly double as vitamin K shot refusals rise
Two large US studies tie a rise in newborn vitamin K shot refusals to sharply higher infant bleeding.
Objective Facts
Two studies published November 5 in JAMA and JAMA Pediatrics, drawing on Epic Cosmos health records, found that fewer US newborns are getting the vitamin K shot and that more infants are being diagnosed with bleeding. The Virginia Commonwealth University analysis of more than 11 million infants found vitamin K deficiency bleeding diagnoses climbed from 189 in 2017 to 1,764 in 2025, with the 2025 figure roughly double that of 2024, while shot receipt fell from 97.7% to 95%. The Children's Hospital of Philadelphia study of 5.2 million infants found nonreceipt more than doubled to 6.8% and estimated one extra bleeding event for every 114 newborns who skip the shot. Both teams said their data show association rather than proof of cause. HHS said it still backs the shot, while Democratic lawmakers want federal tracking of refusals and bleeding.
Left-Leaning Perspective
ABC News, in a piece by Dr. Jade Cobern and Mary Kekatos, framed the studies around pediatricians who see the results firsthand, including Idaho pediatrician Dr. Thomas Patterson, who said refusals were rare before about 2022 and that he knows of two infant deaths tied to refusal in his state. The Washington Post report, as relayed by HealthDay and PhillyVoice, led with co-author Dr. Steven Woolf calling the trend a reversal of public health progress. HealthDay noted the researchers linked the trend to rising vaccine doubt and recent federal moves to overhaul childhood vaccine schedules, and that Democratic lawmakers pointed to Health Secretary Robert F. Kennedy Jr.
Right-Leaning Perspective
The Epoch Times, in a report by Zachary Stieber, covered both studies and organized its analysis under the question of lost trust in medicine. It carried the HHS spokesperson's statement backing the shot while blaming falling uptake on COVID-era mandates and inconsistent messaging under the Biden administration, and it did not name Kennedy. The only outside clinician quoted, California pediatrician Dr. Joel Warsh, supports the shot but said distrust is the larger story. We found no coverage of the new studies from Fox News, The Wall Street Journal, National Review or the New York Post.
Deep Dive
Doctors in the United States have given newborns a single vitamin K injection since 1961 because babies are born with very little of the vitamin and can bleed into the brain or gut weeks after birth. The two November 5 papers are the largest US look at what happens when that dose is skipped. The VCU research letter in JAMA Pediatrics counted vitamin K deficiency bleeding diagnoses rising from 24.0 to 107.4 per 100,000 infants between 2017 and 2025, and found that only 19.2% of affected babies had received the shot. The CHOP study in JAMA estimated that infants without the injection had 33 recorded brain bleeds per 10,000 births versus 13.2 among those who got it, and that one extra bleeding event occurs for every 114 newborns not given the shot. Coverage that ties the trend to Kennedy rests on timing: Reuters reported refusals accelerated in 2026 after his January vaccine schedule changes, but the rise began years earlier, as the 2017 baseline shows and as HHS has argued. The HHS account blaming pandemic mandates also fits that longer timeline, though it leaves out that the current department has not committed to tracking the problem. Both studies carry real limits that partisan framing tends to skip. They rely on diagnosis codes, underrepresent home and birth-center births, cannot tell whether babies got oral vitamin K, and found bleeding rising among infants who did get the shot, which the authors said could reflect better detection or sicker mother and infant pairs. The next questions are practical. The JAMA editorial asked for an FDA-regulated oral vitamin K product for families who refuse the injection, and Dr. Howard Gill told HealthDay that oral doses work less well and may need repeating. Whether the CDC starts national surveillance, as Schrier and Alsobrooks have asked, is unresolved. With Democrats set to take control of Congress in January, health committee oversight of HHS on childhood prevention could bring the issue back to hearings.